CinCor Pharma
Marc De Garidel has 30 years of experience in the global pharmaceutical industry. Most recently, he was CEO of AZTherapies.
This person is not in any offices
CinCor Pharma
CinCor is a clinical-stage cardiorenal therapeutics company with a novel clinical-stage candidate, CIN-107 that has the potential to dramatically expand therapeutic options for patients suffering from hypertension and its associated risks.